47045-BDI-Z-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria Burundi, Multicomponent, United Nations Development Programme Goals: Contribuer à mettre fin aux épidémies du VIH, des IST, des Hépatites virales comme ménace pour la santé publique d'ici 2030 au Burundi, en Réduisant les nouvelles infections , les décès et la discrimination/stigmatisation // Contribute to ending the epidemics of HIV, STIs and viral hepatitis as a public health threat by 2030 in Burundi, by reducing new infections, deaths and discrimination/stigmatization; Mettre fin à la tendance épidémique de la tuberculose au Burundi afin de libérer la population du fardeau lié à la TB et ses comorbidité pour sa participation au dévelopment du pays // Put an end to the epidemic trend of tuberculosis in Burundi in order to free the population from the burden of TB and its co-morbidities and allow them to participate in the country's development; Doter à la population vivant sur le territoire burundais des outils et services les plus efficaces de lutte contre le Paludisme (mission) // Provide the population living in Burundi with the most effective tools and services to fight malaria (mission); Contribuer à la réduction de la mortalité, des handicaps et invalidités évitables par l’offre et l’utilisation des services de santé de qualité à toute la population qui en a besoin // Contribute to the reduction of avoidable mortality and disabilities through the provision and use of quality health services to the entire population in need. Objectives: Résultat d’Impact 1 : D’ici 2027, les nouvelles infections à VIH/IST/HV sont réduites d’au moins 70 %, en particulier pour les populations les plus exposées // Impact Outcome 1: By 2027, new HIV/STI/Hep infections are reduced by at least 70%, particularly for most-at-risk populations; Résultat d’Impact 2 : D’ici 2027, la morbi-mortalité liée au VIH /IST est réduite d’au moins 70% et d’au moins 65% des décès liés aux hépatites virales // Impact Outcome 2: By 2027, HIV/STI-related morbidity and mortality is reduced by at least 70% and viral hepatitis-related deaths by at least 65%; Résultat d’impact 3 : D’ici 2027, l’environnement lié aux droits humains et au genre est amélioré pour lever les barrières de l’accès aux services de prévention de prise e charge du VIH, des IST et des HV y compris la suppression des coûts catastrophiques // Impact outcome 3: By 2027, the human rights and gender environment is improved to remove barriers to accessing HIV, STI and Hepatitis prevention and care services, including the elimination of catastrophic costs; Résultat d’impact 4 : D’ici 2027, la gouvernance est renforcée pour maintenir les performances, l’efficience, la redevabilité et la durabilité de la réponse nationale au VIH/IST/HV sous le leadership du CNLS // Impact outcome 4: By 2027, governance is strengthened to maintain the performance, efficiency, accountability and sustainability of the national response to HIV/STI/Hep under the leadership of the CNLS; D'ici 2027, contribuer à la réduction de la morbidité et de la mortalité due à la tuberculose ainsi que les coûts catastrophique ainsi que la réduction de 75% des décès (par rapport à 2015) et 50% de l'incidence ( par rapport à 2015) // By 2027, contribute to the reduction of morbidity and mortality due to tuberculosis as well as catastrophic costs, with a 75% reduction in deaths (compared to 2015) and a 50% reduction in incidence (compared to 2015); Réduire de 60% la morbidité et à 0% la mortalité liée au Paludisme au Burundi // Reduce malaria-related morbidity by 60% and mortality to 0% in Burundi; D'ici 2026, le score global de complétude et promptitude de la qualité des données du système d'information sanitaire de routine passe respectivement de 81% à 92% et de 56% à 75% // By 2026, the overall score for completeness and timeliness of routine health information system data quality will rise from 81% to 92% and from 56% to 75% respectively. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division Gilles Cesari Fund Portfolio Manager +41 58 791 1700 gilles.cesari@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Burundi Malaria Multicomponent, RSSH HIV Tuberculosis Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Facility-based testing for adolescent girls and young women (AGYW) and their male sexual partners programs HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Early infant diagnosis and follow-up HIV testing for exposed infants HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Integrated testing of pregnant women for HIV, syphilis and hepatitis B HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Post-natal infant prophylaxis HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Prevention of incident HIV among pregnant and breastfeeding women HIV -> Elimination of vertical transmission of HIV, syphilis and hepatitis B -> Retention support for pregnant and breastfeeding women (facility and community) HIV -> Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Community empowerment for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM HIV -> Prevention package for other vulnerable populations (OVP) -> Condom and lubricant programming for OVP HIV -> Prevention package for other vulnerable populations (OVP) -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for OVP HIV -> Prevention package for people in prisons and other closed settings -> Condom and lubricant programming for prisoners HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Community empowerment for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Condom and lubricant programming for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> HIV prevention communication, information and demand creation for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for PUD HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD HIV -> Prevention package for sex workers, their clients and other sexual partners -> Community empowerment for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> HIV prevention communication, information and demand creation for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Pre-exposure prophylaxis (PrEP) programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy for human rights HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> Legal literacy ("Know Your Rights") (HIV/TB) HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Integrated management of common co-infections and co-morbidities (adults and children) HIV -> Treatment, care and support -> Treatment monitoring - Drug resistance HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Malaria -> Case management -> Epidemic preparedness Malaria -> Case management -> Facility-based treatment Malaria -> Case management -> Integrated community case management (iCCM) Malaria -> Specific prevention interventions (SPI) -> Intermittent preventive treatment (IPT) - In pregnancy Malaria -> Specific prevention interventions (SPI) -> Perennial malaria chemoprevention (PMC) Malaria -> Specific prevention interventions (SPI) -> Removing human rights and gender-related barriers to specific prevention interventions Malaria -> Specific prevention interventions (SPI) -> Social and behavior change (SBC) (Specific prevention interventions) Malaria -> Vector control -> Indoor residual spraying (IRS) Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: ANC Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: EPI Malaria -> Vector control -> Insecticide treated nets (ITNs) - Continuous distribution: community-based Malaria -> Vector control -> Insecticide treated nets (ITNs) - Mass campaign: universal Malaria -> Vector control -> Social and behavior change (SBC) (Vector control) Multicomponent -> Program management -> Coordination and management of national disease control programs Multicomponent -> Program management -> Grant management RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Data quality RSSH -> RSSH: Monitoring and evaluation systems -> RSSH/PP: Surveillance for priority epidemic-prone diseases and events RSSH -> RSSH: Monitoring and evaluation systems -> Routine reporting RSSH -> RSSH: Monitoring and evaluation systems -> Surveys Tuberculosis -> Collaboration with other providers and sectors -> Collaboration with other programs/sectors Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Children and adolescents Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Miners and mining communities Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Mobile population (migrants/refugees/IDPs) Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Others Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - People in prisons/jails/detention centers Tuberculosis -> Key and vulnerable populations (KVP) - TB/DR-TB -> KVP - Urban poor/slum dwellers Tuberculosis -> TB diagnosis, treatment and care -> TB screening and diagnosis Tuberculosis -> TB diagnosis, treatment and care -> TB treatment, care and support Tuberculosis -> TB/DR-TB Prevention -> Infection prevention and control (IPC) Tuberculosis -> TB/HIV -> TB/HIV - Community care delivery Tuberculosis -> TB/HIV -> TB/HIV - Prevention Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis Tuberculosis -> TB/HIV -> TB/HIV - Treatment and care 19294693.12 66960910.75 23093581.69 77587759.00 Global Fund commitment to BDI-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 9136513.00 Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 31955898.00 Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 36085969.00 Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4487876.00 Global Fund commitment to BDI-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4487876.00 Global Fund disbursement to BDI-Z-UNDPP01 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -409379.00 Global Fund commitment to BDI-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 14885730.00 Global Fund commitment to BDI-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3199377.00 Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 10629139.00 Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 11521273.94 Global Fund commitment to BDI-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -1057214.00 Global Fund commitment to BDI-Z-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 9714199.85 Global Fund disbursement to BDI-Z-UNDPP01 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 19294693.13 Expenditure reported by United Nations Development Programme for BDI-Z-UNDPP01, Jan 2024 to Dec 2024. United Nations Development Programme 53449213.34 Expenditure reported by United Nations Development Programme for BDI-Z-UNDPP01, Jan 2025 to Dec 2025. United Nations Development Programme An overview of a grant over its lifetime. General terms and conditions which apply to Global Fund grants. Funding Request of funding request FR1581-BDI-Z. Funding Request of funding request FR1581-BDI-Z. 1 - Personal Data. (1) Principles. Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with any law and/or policy applicable to it; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons. (3) The Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data. Prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any law or regulation applicable to the Principal Recipient. 2 - Under Article 3 of the UNDP-Global Fund Grant Regulations, the “Grant” consists of “funds as stated in the relevant Grant Confirmation together with any funds previously granted by the Global Fund to the Principal Recipient for the Program”. In this regard, please note that where the Global Fund has approved the use under the current Grant Confirmation of grant funds disbursed to the Principal Recipient under a previous Grant Agreement for the Program (“Previously Disbursed Grant Funds”), the Global Fund may reduce the amount of Grant Funds that remains uncommitted set forth in Section 3.6 of the Grant Confirmation by the amount of any Previously Disbursed Grant Funds, upon written notification to the Principal Recipient. 4 - The Principal Recipient shall take all appropriate and necessary actions to ensure that it and any Sub-recipient complies with the “Asset Guidelines for Global Fund Grant Transitions” dated 2 June 2023 (as amended from time to time), the provisions of which are incorporated by reference into the Grant Agreement. 5 - (1)  In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of 17, 295,895 USD (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 4.5 (1)(a) and 4.5 (1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Principal Recipient acknowledges and agrees that the Host Country shall, as set out in the “Lettre d’engagement de co-financement GC7”, dated 10 November 2023 (the “Commitment Letter”), unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of USD 18,385,631 from 2024-2026 (inclusive), comprising investments in: i. HIV of USD 2,775,056; ii. TB of USD 308,080; iii. Malaria of USD 5,322,169; and iv. RSSH of USD 9,980,326 (b) fulfil the programmatic commitments as stipulated in Section 1.3 of the Commitment Letter; and (c) provide to the Global Fund, by no later than 31 December of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the approved annual budget for HIV / TB / Malaria and related RSSH commitments for the upcoming year; ii. the total expenditure for HIV / TB / Malaria and related RSSH commitment in the previous fiscal year. Other information indicated in section 2 of the Commitment Letter. Module: Case management. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 5656533; Denominator: 5782482. Numerator: 3525654.15; Denominator: 3634695. Numerator: 3525654.15; Denominator: 3634695. Numerator: 2103215; Denominator: 2147787. Numerator: 2103215; Denominator: 2147787. Numerator: 4986542.8; Denominator: 5036912. Numerator: 4185594; Denominator: 4288476. Numerator: 2493271.44; Denominator: 2518456. Numerator: 2493271.44; Denominator: 2518456. Numerator: 2275964; Denominator: 2321403. Numerator: 1477139; Denominator: 1505540. Numerator: 798825; Denominator: 815760. Numerator: 2328292; Denominator: 2351810. Numerator: 4656584; Denominator: 4703620. Numerator: 3389239; Denominator: 3488440. Numerator: 2328292; Denominator: 2351810. Numerator: 1354064; Denominator: 1418301. Numerator: 2341388; Denominator: 2409249. Numerator: 1047847; Denominator: 1079169. Numerator: 2029433; Denominator: 2029433. Numerator: 2029433; Denominator: 2029433. Module: Case management. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1317646; Denominator: 1340208. Numerator: 225317; Denominator: 229176. Numerator: 225317; Denominator: 229176. Numerator: 1092328.53; Denominator: 1111032. Numerator: 1092328.53; Denominator: 1111032. Numerator: 1658362; Denominator: 1658362. Numerator: 1221428; Denominator: 1202182. Numerator: 829181; Denominator: 829181. Numerator: 829181; Denominator: 829181. Numerator: 587641; Denominator: 579192. Numerator: 153310; Denominator: 164684. Numerator: 434331; Denominator: 414508. Numerator: 1806192; Denominator: 1806192. Numerator: 925083; Denominator: 914935. Numerator: 903096; Denominator: 903096. Numerator: 903096; Denominator: 903096. Numerator: 332284; Denominator: 331648. Numerator: 226852; Denominator: 238422. Numerator: 698231; Denominator: 676513. Numerator: 899982; Denominator: 899982. Numerator: 899982; Denominator: 899982. Module: Case management. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 11099430; Denominator: 11117138; Percentage: 99.84%. Numerator: 290409; Denominator: 291770; Percentage: 99.53%. Numerator: 290409; Denominator: 291770; Percentage: 99.53%. Numerator: 362982; Denominator: 364284; Percentage: 99.64%. Numerator: 362982; Denominator: 364284; Percentage: 99.64%. Numerator: 1654109; Denominator: 11099430; Percentage: 14.9%. Numerator: 9445321; Denominator: 11099430; Percentage: 85.1%. Numerator: 4829323.84; Denominator: 4834158; Percentage: 99.9%. Numerator: 9658647.6; Denominator: 9668316; Percentage: 99.9%. Numerator: 8757331; Denominator: 8774091; Percentage: 99.81%. Numerator: 4829323.84; Denominator: 4834158; Percentage: 99.9%. Numerator: 4470342; Denominator: 4477350; Percentage: 99.84%. Numerator: 2865256; Denominator: 2869094; Percentage: 99.87%. Numerator: 1605086; Denominator: 1608251; Percentage: 99.8%. Numerator: 4509767; Denominator: 4514281; Percentage: 99.9%. Numerator: 9019534; Denominator: 9028562; Percentage: 99.9%. Numerator: 7289923; Denominator: 7295063; Percentage: 99.93%. Numerator: 4509767; Denominator: 4514281; Percentage: 99.9%. Numerator: 3194047; Denominator: 3196582; Percentage: 99.92%. Numerator: 4861896; Denominator: 4864601; Percentage: 99.94%. Numerator: 2429843; Denominator: 2432278; Percentage: 99.9%. Numerator: 1284425. Numerator: 6005498. Numerator: 3891586; Denominator: 3895481; Percentage: 99.9%. Numerator: 3891586; Denominator: 3895481; Percentage: 99.9%. Module: Case management. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1721513; Denominator: 1721513; Percentage: 100%. Numerator: 368346; Denominator: 368346; Percentage: 100%. Numerator: 368346; Denominator: 368346; Percentage: 100%. Numerator: 1353167; Denominator: 1353167; Percentage: 100%. Numerator: 1353167; Denominator: 1353167; Percentage: 100%. Numerator: 1721513; Denominator: 1721513; Percentage: 100%. Numerator: 1065093; Denominator: 1065093; Percentage: 100%. Numerator: 2130186; Denominator: 2130186; Percentage: 100%. Numerator: 1632183; Denominator: 2175975; Percentage: 75.01%. Numerator: 1065093; Denominator: 1065093; Percentage: 100%. Numerator: 758202; Denominator: 1110383; Percentage: 68.28%. Numerator: 215727; Denominator: 711535; Percentage: 30.32%. Numerator: 542475; Denominator: 398846; Percentage: 136.01%. Numerator: 1160038; Denominator: 1160038; Percentage: 100%. Numerator: 2320076; Denominator: 2320076; Percentage: 100%. Numerator: 1207141; Denominator: 2024381; Percentage: 59.63%. Numerator: 1160038; Denominator: 1160038; Percentage: 100%. Numerator: 438027; Denominator: 887052; Percentage: 49.38%. Numerator: 334520; Denominator: 1349927; Percentage: 24.78%. Numerator: 872621; Denominator: 674957; Percentage: 129.29%. Numerator: 1207141. Numerator: 1156038; Denominator: 1156038; Percentage: 100%. Numerator: 1156038; Denominator: 1156038; Percentage: 100%. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 7879; Denominator: 11570. Numerator: 5805.2; Denominator: 19612. Numerator: 14513; Denominator: 19612. Numerator: 14668; Denominator: 19612. Numerator: 14513; Denominator: 19612. Numerator: 14668; Denominator: 19612. Numerator: 15463; Denominator: 20082. Numerator: 15364; Denominator: 20082. Numerator: 7731.5; Denominator: 20082. Numerator: 15463; Denominator: 20082. Numerator: 15364; Denominator: 20082. Numerator: 3421; Denominator: 9385. Numerator: 4688; Denominator: 9385. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 38010; Denominator: 63732. Numerator: 42867; Denominator: 61239. Numerator: 57189; Denominator: 61239. Numerator: 17146.8; Denominator: 61239. Numerator: 42867; Denominator: 61239. Numerator: 57189; Denominator: 61239. Numerator: 47032; Denominator: 62709. Numerator: 42405; Denominator: 62709. Numerator: 23516; Denominator: 62709. Numerator: 47032; Denominator: 62709. Numerator: 42405; Denominator: 62709. Numerator: 26257; Denominator: 65906. Numerator: 34462; Denominator: 65906. Module: Differentiated HIV Testing Services. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 2648; Denominator: 928; Percentage: 285.34%. Numerator: 482; Denominator: 928; Percentage: 51.94%. Numerator: 2166; Denominator: 928; Percentage: 233.41%. Numerator: 1493.2; Denominator: 9824; Percentage: 15.2%. Numerator: 3733; Denominator: 9824; Percentage: 38%. Numerator: 4405; Denominator: 9824; Percentage: 44.84%. Numerator: 3733; Denominator: 9824; Percentage: 38%. Numerator: 4405; Denominator: 9824; Percentage: 44.84%. Numerator: 0. Numerator: 4405. Numerator: 2414.5; Denominator: 10060; Percentage: 24%. Numerator: 4829; Denominator: 10060; Percentage: 48%. Numerator: 4022; Denominator: 10060; Percentage: 39.98%. Numerator: 4829; Denominator: 10060; Percentage: 48%. Numerator: 4022; Denominator: 10060; Percentage: 39.98%. Numerator: 1811; Denominator: 6280; Percentage: 28.84%. Numerator: 2423; Denominator: 6280; Percentage: 38.58%. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 46; Denominator: 46; Percentage: 100%. Numerator: 46; Denominator: 46; Percentage: 100%. Numerator: 0; Denominator: 46; Percentage: 0%. Numerator: 0; Denominator: 46; Percentage: 0%. Numerator: 21; Denominator: 21; Percentage: 100%. Numerator: 21; Denominator: 21; Percentage: 100%. Numerator: 0; Denominator: 46; Percentage: 0%. Numerator: 0; Denominator: 46; Percentage: 0%. Numerator: 25; Denominator: 25; Percentage: 100%. Numerator: 25; Denominator: 25; Percentage: 100%. Numerator: 46; Denominator: 46; Percentage: 100%. Numerator: 46; Denominator: 46; Percentage: 100%. Numerator: 46; Denominator: 46; Percentage: 100%. Numerator: 24; Denominator: 24; Percentage: 100%. Numerator: 48; Denominator: 48; Percentage: 100%. Numerator: 47; Denominator: 47; Percentage: 100%. Numerator: 24; Denominator: 24; Percentage: 100%. Numerator: 24; Denominator: 24; Percentage: 100%. Numerator: 24; Denominator: 24; Percentage: 100%. Numerator: 0; Denominator: 0. Numerator: 3; Denominator: 21; Percentage: 14.29%. Numerator: 0. Numerator: 21; Denominator: 25; Percentage: 84%. Numerator: 24. Numerator: 54; Denominator: 54; Percentage: 100%. Numerator: 44; Denominator: 44; Percentage: 100%. Numerator: 27; Denominator: 27; Percentage: 100%. Numerator: 27; Denominator: 27; Percentage: 100%. Numerator: 23; Denominator: 23; Percentage: 100%. Numerator: 22; Denominator: 2. Numerator: 1; Denominator: 1; Percentage: 100%. Numerator: 2; Denominator: 2; Percentage: 100%. Numerator: 0. Numerator: 42; Denominator: 42; Percentage: 100%. Numerator: 23. Numerator: 32; Denominator: 32; Percentage: 100%. Numerator: 32; Denominator: 32; Percentage: 100%. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 290. Numerator: 402. Numerator: 307. Numerator: 201. Numerator: 201. Numerator: 147. Numerator: 450. Numerator: 305; Denominator: 450; Percentage: 67.78%. Numerator: 225. Numerator: 225. Numerator: 159; Denominator: 450; Percentage: 35.33%. Numerator: 269. Numerator: 269. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2195. Numerator: 1279. Numerator: 2558. Numerator: 2460. Numerator: 1279. Numerator: 1249. Numerator: 1348. Numerator: 2697. Numerator: 2563; Denominator: 2697; Percentage: 95.03%. Numerator: 1349. Numerator: 1252; Denominator: 2697; Percentage: 46.42%. Numerator: 1421. Numerator: 1421. Module: Drug-resistant (DR)-TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 60; Denominator: 60; Percentage: 100%. Numerator: 60; Denominator: 60; Percentage: 100%. Numerator: 60; Denominator: 64; Percentage: 93.75%. Percentage: 94%. Numerator: 44; Denominator: 50; Percentage: 88%. Percentage: 94%. Percentage: 94%. Numerator: 25; Denominator: 30; Percentage: 83.33%. Numerator: 25. Percentage: 94%. Percentage: 94%. Numerator: 40; Denominator: 47; Percentage: 85.11%. Percentage: 94%. Numerator: 20; Denominator: 24; Percentage: 83.33%. Numerator: 20. Percentage: 94%. Percentage: 94%. Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 2859; Denominator: 5153; Percentage: 55.48%. Numerator: 2656; Denominator: 5153; Percentage: 51.54%. Numerator: 2656; Denominator: 5153; Percentage: 51.54%. Numerator: 203; Denominator: 5153; Percentage: 3.94%. Numerator: 203; Denominator: 5153; Percentage: 3.94%. Numerator: 1131.2; Denominator: 4940; Percentage: 22.9%. Numerator: 2828; Denominator: 4940; Percentage: 57.2%. Numerator: 1412; Denominator: 4940; Percentage: 28.58%. Numerator: 1696.8; Denominator: 4940; Percentage: 34.35%. Numerator: 637; Denominator: 4940; Percentage: 12.89%. Numerator: 635. Numerator: 2. Numerator: 3150; Denominator: 4838; Percentage: 65.1%. Numerator: 1243; Denominator: 3055; Percentage: 40.69%. Numerator: 1575; Denominator: 4838; Percentage: 32.55%. Numerator: 1575; Denominator: 4838; Percentage: 32.55%. Numerator: 670; Denominator: 3055; Percentage: 21.93%. Numerator: 667. Numerator: 3. Numerator: 1688; Denominator: 4810; Percentage: 35.09%. Numerator: 1688; Denominator: 4810; Percentage: 35.09%. Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 476365; Denominator: 655970; Percentage: 72.62%. Numerator: 4858; Denominator: 629499; Percentage: 0.77%. Numerator: 4858; Denominator: 629499; Percentage: 0.77%. Numerator: 540106; Denominator: 675132; Percentage: 80%. Numerator: 643512; Denominator: 675132; Percentage: 95.32%. Numerator: 216042.4; Denominator: 675132; Percentage: 32%. Numerator: 324063.6; Denominator: 675132; Percentage: 48%. Numerator: 339932; Denominator: 675132; Percentage: 50.35%. Numerator: 1173. Numerator: 299270; Denominator: 687976; Percentage: 43.5%. Numerator: 598540; Denominator: 687976; Percentage: 87%. Numerator: 607495; Denominator: 687976; Percentage: 88.3%. Numerator: 299270; Denominator: 687976; Percentage: 43.5%. Numerator: 283848; Denominator: 687976; Percentage: 41.26%. Numerator: 607. Numerator: 332897; Denominator: 700835; Percentage: 47.5%. Numerator: 332897; Denominator: 700835; Percentage: 47.5%. Module: Prevention package for men who have sex with men (MSM) and their sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 13996; Denominator: 11570. Numerator: 15101; Denominator: 19612. Numerator: 15369; Denominator: 19612. Numerator: 6040.4; Denominator: 19612. Numerator: 15101; Denominator: 19612. Numerator: 15369; Denominator: 19612. Numerator: 15865; Denominator: 20082. Numerator: 25436; Denominator: 20082. Numerator: 7932.5; Denominator: 20082. Numerator: 15865; Denominator: 20082. Numerator: 25436; Denominator: 20082. Numerator: 3801; Denominator: 9385. Numerator: 5209; Denominator: 9385. Module: Prevention package for people who use drugs (PUD) and their sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 6022; Denominator: 928; Percentage: 648.92%. Numerator: 1096; Denominator: 928; Percentage: 118.1%. Numerator: 4926; Denominator: 928; Percentage: 530.82%. Numerator: 2711.6; Denominator: 9824; Percentage: 27.6%. Numerator: 6779; Denominator: 9824; Percentage: 69%. Numerator: 19392; Denominator: 9824; Percentage: 197.39%. Numerator: 6779; Denominator: 9824; Percentage: 69%. Numerator: 19392; Denominator: 9824; Percentage: 197.39%. Numerator: 0. Numerator: 21959. Numerator: 7444; Denominator: 10060; Percentage: 74%. Numerator: 9060; Denominator: 10060; Percentage: 90.06%. Numerator: 3722; Denominator: 10060; Percentage: 37%. Numerator: 7444; Denominator: 10060; Percentage: 74%. Numerator: 9060; Denominator: 10060; Percentage: 90.06%. Numerator: 2481; Denominator: 6280; Percentage: 39.51%. Numerator: 3423; Denominator: 6280; Percentage: 54.51%. Module: Prevention package for sex workers, their clients and other sexual partners. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 58402; Denominator: 63732. Numerator: 57565; Denominator: 61239. Numerator: 56247; Denominator: 61239. Numerator: 28782.5; Denominator: 61239. Numerator: 57565; Denominator: 61239. Numerator: 56247; Denominator: 61239. Numerator: 29786.5; Denominator: 62709. Numerator: 59573; Denominator: 62709. Numerator: 91906; Denominator: 62709. Numerator: 59573; Denominator: 62709. Numerator: 91906; Denominator: 62709. Numerator: 31635; Denominator: 65906. Numerator: 41521; Denominator: 65906. Module: Specific prevention interventions (SPI). Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 0. Numerator: 0; Denominator: 0. Numerator: 0. Numerator: 0. Numerator: 0; Denominator: 0. Numerator: 25195.5; Denominator: 100782; Percentage: 25%. Numerator: 57; Denominator: 30222; Percentage: 0.19%. Numerator: 25195.5; Denominator: 100782; Percentage: 25%. Numerator: 57; Denominator: 30222; Percentage: 0.19%. Numerator: 51341; Denominator: 102682; Percentage: 50%. Module: Specific prevention interventions (SPI). Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 303901; Denominator: 517402. Numerator: 164883; Denominator: 267061. Numerator: 329766; Denominator: 534122. Numerator: 274594; Denominator: 531856. Numerator: 164883; Denominator: 267061. Numerator: 134383; Denominator: 278980. Numerator: 190056; Denominator: 289102. Numerator: 380112; Denominator: 578204. Numerator: 227926; Denominator: 545459. Numerator: 190056; Denominator: 289102. Numerator: 98946; Denominator: 269552. Numerator: 232816; Denominator: 329115. Numerator: 232816; Denominator: 329115. Module: TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Module: TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 1863; Denominator: 3387. Numerator: 4168; Denominator: 7310. Numerator: 3388; Denominator: 8001. Numerator: 2084; Denominator: 3655. Numerator: 2084; Denominator: 3655. Numerator: 1741; Denominator: 4119. Numerator: 2248; Denominator: 3746. Numerator: 4497; Denominator: 7493. Numerator: 3555; Denominator: 8615. Numerator: 2249; Denominator: 3747. Numerator: 2015; Denominator: 4255. Numerator: 2496; Denominator: 3840. Numerator: 2496; Denominator: 3840. Module: TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 164; Denominator: 4320. Numerator: 108; Denominator: 2156. Numerator: 216; Denominator: 4313. Numerator: 303; Denominator: 4987. Numerator: 108; Denominator: 2157. Numerator: 150; Denominator: 1105. Numerator: 155; Denominator: 2210. Numerator: 310; Denominator: 4421. Numerator: 174; Denominator: 8615. Numerator: 155; Denominator: 2211. Numerator: 81; Denominator: 4255. Numerator: 307; Denominator: 3840. Numerator: 308; Denominator: 3840. Module: TB diagnosis, treatment and care. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 6741; Denominator: 7105. Numerator: 3388; Denominator: 3566. Numerator: 6776; Denominator: 7132. Numerator: 6981; Denominator: 7539. Numerator: 3388; Denominator: 3566. Numerator: 3550; Denominator: 3860. Numerator: 3473; Denominator: 3655. Numerator: 6946; Denominator: 7310. Numerator: 7237; Denominator: 7781. Numerator: 3473; Denominator: 3655. Numerator: 3581; Denominator: 3871. Numerator: 3560; Denominator: 3747. Numerator: 3560; Denominator: 3747. Module: TB/DR-TB Prevention. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Module: TB/HIV. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 397; Denominator: 397. Numerator: 208; Denominator: 208. Numerator: 417; Denominator: 417. Numerator: 467; Denominator: 472. Numerator: 209; Denominator: 209. Numerator: 246; Denominator: 248. Numerator: 427; Denominator: 427. Numerator: 450; Denominator: 489. Numerator: 213; Denominator: 213. Numerator: 214; Denominator: 214. Numerator: 241; Denominator: 261. Numerator: 219; Denominator: 219. Numerator: 219; Denominator: 219. Module: TB/HIV. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2917; Denominator: 3286; Percentage: 88.77%. Numerator: 1616; Denominator: 3286; Percentage: 49.18%. Numerator: 1616; Denominator: 3286; Percentage: 49.18%. Numerator: 779; Denominator: 3286; Percentage: 23.71%. Numerator: 779; Denominator: 3286; Percentage: 23.71%. Numerator: 522; Denominator: 3286; Percentage: 15.89%. Numerator: 522; Denominator: 3286; Percentage: 15.89%. Numerator: 1424; Denominator: 3286; Percentage: 43.34%. Numerator: 1424; Denominator: 3286; Percentage: 43.34%. Numerator: 1493; Denominator: 3286; Percentage: 45.44%. Numerator: 1493; Denominator: 3286; Percentage: 45.44%. Numerator: 458; Denominator: 498; Percentage: 91.97%. Numerator: 916; Denominator: 996; Percentage: 92%. Numerator: 3622; Denominator: 5468; Percentage: 66.24%. Numerator: 458; Denominator: 498; Percentage: 91.97%. Numerator: 1874; Denominator: 2658; Percentage: 70.5%. Numerator: 1808. Numerator: 34. Numerator: 32. Numerator: 1211. Numerator: 663. Numerator: 946; Denominator: 996; Percentage: 95%. Numerator: 4295; Denominator: 4527; Percentage: 94.88%. Numerator: 473; Denominator: 498; Percentage: 94.98%. Numerator: 473; Denominator: 498; Percentage: 94.98%. Numerator: 2306; Denominator: 2375; Percentage: 97.09%. Numerator: 2243. Numerator: 46. Numerator: 17. Numerator: 1495. Numerator: 811. Numerator: 423; Denominator: 432; Percentage: 97.92%. Numerator: 423; Denominator: 432; Percentage: 97.92%. Module: TB/HIV. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 397; Denominator: 6788; Percentage: 5.85%. Numerator: 397; Denominator: 6788; Percentage: 5.85%. Numerator: 6761; Denominator: 6788; Percentage: 99.6%. Numerator: 6366; Denominator: 6788; Percentage: 93.78%. Numerator: 6366; Denominator: 6788; Percentage: 93.78%. Numerator: 6736; Denominator: 6788; Percentage: 99.23%. Numerator: 6736; Denominator: 6788; Percentage: 99.23%. Numerator: 7310; Denominator: 7310; Percentage: 100%. Numerator: 8001; Denominator: 8001; Percentage: 100%. Numerator: 3655; Denominator: 3655; Percentage: 100%. Numerator: 3655; Denominator: 3655; Percentage: 100%. Numerator: 4141; Denominator: 4119; Percentage: 100.53%. Numerator: 3912. Numerator: 248. Numerator: 0. Numerator: 3746; Denominator: 3746; Percentage: 100%. Numerator: 7493; Denominator: 7493; Percentage: 100%. Numerator: 8498; Denominator: 8615; Percentage: 98.64%. Numerator: 3747; Denominator: 3747; Percentage: 100%. Numerator: 4265; Denominator: 4255; Percentage: 100.24%. Numerator: 4004. Numerator: 261. Numerator: 0. Numerator: 3840; Denominator: 3840; Percentage: 100%. Numerator: 3840; Denominator: 3840; Percentage: 100%. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 72846; Denominator: 75508. Numerator: 48129; Denominator: 75508. Numerator: 48129; Denominator: 75508. Numerator: 24717; Denominator: 75508. Numerator: 24717; Denominator: 75508. Numerator: 72697; Denominator: 76523. Numerator: 76898; Denominator: 76523. Numerator: 72345; Denominator: 76523. Numerator: 72697; Denominator: 76523. Numerator: 76898; Denominator: 76523. Numerator: 50269; Denominator: 77597. Numerator: 26629; Denominator: 77597. Numerator: 73411; Denominator: 77275. Numerator: 75192; Denominator: 78100. Numerator: 73054; Denominator: 77275. Numerator: 73411; Denominator: 77275. Numerator: 75192; Denominator: 78100. Numerator: 49249; Denominator: 78100. Numerator: 25943; Denominator: 78100. Numerator: 73727; Denominator: 77939. Numerator: 74042; Denominator: 77939. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 2707; Denominator: 6658. Numerator: 1348; Denominator: 6658. Numerator: 1348; Denominator: 6658. Numerator: 1359; Denominator: 6658. Numerator: 1359; Denominator: 6658. Numerator: 3068; Denominator: 6527. Numerator: 2201; Denominator: 6527. Numerator: 3023; Denominator: 6527. Numerator: 3068; Denominator: 6527. Numerator: 2201; Denominator: 6527. Numerator: 1114; Denominator: 3691. Numerator: 1087; Denominator: 3691. Numerator: 3182; Denominator: 6462. Numerator: 3296; Denominator: 6462. Numerator: 1948; Denominator: 4100. Numerator: 3296; Denominator: 6462. Numerator: 1948; Denominator: 4100. Numerator: 962; Denominator: 4100. Numerator: 986; Denominator: 4100. Numerator: 3440; Denominator: 6398. Numerator: 3583; Denominator: 6398. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 57007; Denominator: 75553. Numerator: 54436; Denominator: 72846. Numerator: 54436; Denominator: 72846. Numerator: 2571; Denominator: 2707. Numerator: 2571; Denominator: 2707. Numerator: 36631; Denominator: 48129. Numerator: 36631; Denominator: 48129. Numerator: 17805; Denominator: 24717. Numerator: 17805; Denominator: 24717. Numerator: 68221; Denominator: 79561. Numerator: 63358; Denominator: 79099. Numerator: 27288.4; Denominator: 79561. Numerator: 68221; Denominator: 79561. Numerator: 63358; Denominator: 79099. Numerator: 60947; Denominator: 76898. Numerator: 2411; Denominator: 2201. Numerator: 40606; Denominator: 50269. Numerator: 20341; Denominator: 26629. Numerator: 73540; Denominator: 81223. Numerator: 58647; Denominator: 77140. Numerator: 36770; Denominator: 81223. Numerator: 73540; Denominator: 81223. Numerator: 58647; Denominator: 77140. Numerator: 56725; Denominator: 75192. Numerator: 1922; Denominator: 1948. Numerator: 38578; Denominator: 49249. Numerator: 18147; Denominator: 25943. Numerator: 39259; Denominator: 82458. Numerator: 78518; Denominator: 82458. Module: Treatment, care and support. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 4158; Denominator: 5153. Numerator: 1740; Denominator: 4940. Numerator: 4350; Denominator: 4940. Numerator: 2620; Denominator: 4940. Numerator: 2610; Denominator: 4940. Numerator: 1409; Denominator: 4940. Numerator: 4500; Denominator: 4838. Numerator: 1986; Denominator: 3055. Numerator: 2250; Denominator: 4838. Numerator: 2250; Denominator: 4838. Numerator: 903; Denominator: 3055. Numerator: 2250; Denominator: 4810. Numerator: 2250; Denominator: 4810. Module: Vector control. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Module: Vector control. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Module: Vector control. Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 1083933; Denominator: 1190484. Numerator: 1118896; Denominator: 1177785. Numerator: 1177190; Denominator: 1253245. Numerator: 1118896; Denominator: 1177785. Numerator: 1177190; Denominator: 1253245.